Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Provider Service
6.1 Patient enrolment and strategic planning
6.2 Medical Transcription
6.3 Medical Billing
6.4 Revenue Cycle Management
6.5 Device Monitoring
Chapter 7 Market Segmentation by Payer Services
7.1 Claims Management
7.2 Human Resource Management
7.3 Operational/Administrative Management
7.4 Customer Relationship Management
7.5 Care Management
7.6 Provider Management
7.7 Product Development
7.8 Member Management Services
7.9 Integrated Front-End Services and Back-Office Operations
Chapter 8 Market Segmentation by Pharmaceutical services
8.1 Pharmacovigilance services
8.2 Clinical data management
8.3 Research & Development
8.4 Manufacturing outsourcing
8.5 Non-Clinical Services
8.5.1 Sales and Marketing Services
8.5.1.1 Marketing Services
8.5.1.2 Analytics
8.5.1.3 Forecasting
8.5.1.4 Performance Reporting
8.5.2 Supply Chain Management & Logistics
8.6 Others
Chapter 9 Market Segmentation by Geography
9.1 Asia Pacific
9.1.1 Introduction
9.1.2 China
9.1.3 India
9.1.4 Japan
9.1.5 Australia & New Zealand
9.1.6 Others
9.2 North America
9.2.1 Introduction
9.2.2 United States
9.2.3 Canada
9.2.4 Mexico
9.2.5 Others
9.3 Europe
9.3.1 Introduction
9.3.2 Spain
9.3.3 UK
9.3.4 France
9.3.5 Russia
9.3.6 Italy
9.3.7 Others
9.4 The Middle East and Africa
9.4.1 Introduction
9.4.2 South Africa
9.4.3 Middle East Countries
9.4.4 Others
9.5 South America
9.5.1 Introduction
9.5.2 Argentina
9.5.3 Brazil
9.5.4 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Accenture
11.1.1 Business Overview
11.1.2 Product portfolio
11.1.3 Key Strategy
11.1.4 Recent Developments
11.2 Gebbs
11.3 Eli Global
11.4 IBM
11.5 Genpact
11.6 Quintiles
11.7 Parexel
11.8 United Health Group
11.9 Sutherland
11.10 Truven Health
11.11 Tata Consultancy Services
11.12 Omega Healthcare
11.13 Lonza
11.14 Xerox Corporation
11.15 Firstsource Solutions
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Provider Service 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecast by Payer Services 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecast by Pharmaceutical Services 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
